Maher Abdel-Sattar, PharmD

University of California, San Francisco
3333 California St.
Suite 420, Box 0613
San Francisco, CA
USA 94143-0613

Papers:
3G-4 ERLOTINIB, AFATINIB, AND CISPLATIN/PEMETREXED FOR FIRST-LINE TREATMENT OF ADVANCED EGFR-MUTATION POSITIVE NON-SMALL CELL LUNG CANCER: VALUE-OF-INFORMATION ANALYSIS

Student? yes
SMDM Member? yes